2 Popular Tech Stocks That Recently Plunged More Than 45%

: DOCU | DocuSign, Inc. News, Ratings, and Charts

DOCU – Technology stocks were in relief-rally mode last week and drove the markets higher. However, concerns about the Fed’s decision to increase interest rates, high inflation, and the discovery of the COVID-19 omicron variant could end the tech stock party next year. Therefore, we believe investors should be cautious about betting on popular tech stocks DocuSign (DOCU) and Asana (ASAN), which have both lost more than 45% in price over the past month. Let’s discuss.

Although the tech stocks led the markets higher last week, inflation could end tech stocks’ rally next year. The tech-heavy Nasdaq composite dipped after a three-day winning streak and ended the regular trading session lower yesterday. Even mega-cap tech shares caused U.S. stocks to tumble last week due to investor concerns over the COVID-19 omicron variant.

Furthermore, the Fed is expected to consider speeding up the pace of its tapering to $30 billion per month at its December meeting. This might give the Fed the flexibility to raise interest rates soon, which in turn could increase the interest expense borne by tech companies, reducing their future earnings.

Given this backdrop, we think investors should take care regarding betting on popular tech stocks DocuSign, Inc. (DOCU) and Asana, Inc. (ASAN), which have plunged more than 45% in price over the past month.

DocuSign, Inc. (DOCU)

San Francisco-based DOCU provides cloud-based software in the United States that delivers an e-signature solution to enable businesses to prepare, sign and manage agreements digitally. The company’s products include DocuSign eSignature, DocuSign CLM, DocuSign Insight, and other  products  that include DocuSign Payments and DocuSign Analyzer.

This month, The Schall Law Firm, a shareholder rights litigation firm, started investigating allegations on behalf of investors of DOCU that the company  violated securities laws. The investigation is based on whether DOCU issued false and misleading statements and failed to disclose information pertinent to investors after DOCU announced disappointing year-end financial projections on December 2, 2021. This news may negatively impact DOCU’s price performance in the near term.

DOCU’s total operating expenses for its fiscal third quarter, ended October 31, 2021, increased 29.8% year-over-year to $432.85 million. The company’s loss from operations came in at $3.36 million, and its net loss amounted to $5.68 million during the period.

DOCU’s shares have declined  45.7% in price over the past month and 46.9% over the past three months.

Click here to check out our Cloud Computing Industry Report for 2021

Asana, Inc. (ASAN)

ASAN, in San Francisco,  is a work management platform that enables individuals, team leads, and executives to organize work—from daily tasks to cross-functional strategic initiatives.  The company enables its users to communicate, monitor status, and oversee work across projects to gain real-time insights. ASAN provides various features in its platform, including timeline, app integration, automation, and other features.

During its fiscal third quarter, ended October 31, 2021, ASAN’s total operating expenses grew 39.9% from their year-ago value to $158.84 million. Its loss from operations rose 9.9% from the prior-year quarter to $68.09 million. And the company’s net loss came in at $69.28 million. Also, its loss per share amounted to $0.37 during the period.

ASAN’s EPS is expected to decline 22.7% in the current quarter and 28.6% next quarter. The stock has fallen 48.3% in price over the past month.

Click here to check out our Software Industry Report for 2021

 


DOCU shares were trading at $144.22 per share on Friday morning, down $5.15 (-3.45%). Year-to-date, DOCU has declined -35.12%, versus a 26.10% rise in the benchmark S&P 500 index during the same period.


About the Author: Priyanka Mandal


Priyanka is a passionate investment analyst and financial journalist. After earning a master's degree in economics, her interest in financial markets motivated her to begin her career in investment research. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
DOCUGet RatingGet RatingGet Rating
ASANGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

2 Best Stocks of All Time!

This bear market has me thinking back to my 2 best trades of all time. That being when I bought Amazon (AMZN) and Booking (BKNG) back in 2001 as they were tumbling down in the midst of a bear market...but now enjoying truly phenomenal gains. Let’s discuss what those investments had in common and how that will help us find more big winners in the years ahead. Read on below for more...

:  |  News, Ratings, and Charts

Bears Back in Charge...What Happens Next?

A month ago the bulls were claiming victory as they created a charge back over 4,000 for the S&P 500 (SPY). Since then that false narrative has been peeled away and investors are more honestly looking at the bleak outlook formed by high inflation and a hawkish Fed. That explains why we are back retesting the June lows. Now we have to ponder what comes next and how to trade our way to profits. Read on below for the full story...

:  |  News, Ratings, and Charts

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK), and Bristol-Myers Squibb (BMY), which are currently trading under $100. Read on…

:  |  News, Ratings, and Charts

Cut These 2 Stocks From Your Portfolio Right Now

The Fed succeeding in a ‘soft landing’ seems unlikely. Analysts are expecting a recession soon. So, with the rising odds of the Fed raising rates aggressively, it could be wise to steer clear of fundamentally weak stocks Roblox (RBLX) and Affirm Holdings (AFRM). Read on…

:  |  News, Ratings, and Charts

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK), and Bristol-Myers Squibb (BMY), which are currently trading under $100. Read on…

Read More Stories

More DocuSign, Inc. (DOCU) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All DOCU News